Wakamoto Pharmaceutical Co.,Ltd. (4512.T) JPX

286.00

+1(+0.35%)

Updated at November 14 03:07PM

Currency In JPY

Valuation

Market Cap11B
Enterprise Value8.15B
P/E Ratio-303.9
PEG Ratio2.02
Price/Sales Ratio1.23
Price/Book Ratio0.87
Enterprise/Revenue0.94
Enterprise/EBITDA19.31

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0
Operating Margin-0.06

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue7.79B
Revenue/Share232.62
Gross Profit3.62B
EBITDA438.68M
Net Income64.44M
Diluted EPS1.86

Balance Sheet

Total Cash2.4B
Total Cash/Share69.22
Total Debt100M
Total Debt/Equity0.01
Current Ratio4.44
Book Value Per Share329.06

Price History

52-Week Change21.19
52-Week High377
52-Week Low209
Moving Average 50 Days292.86
Moving Average 200 Days297.38

Statistics

Average Volume79,021
Shares Outstanding34.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3
Trailing Annual Dividend Yield1.05
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A